# Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer

> **NCT02415101** · NA · COMPLETED · sponsor: **Karolinska University Hospital** · enrollment: 202 (actual)

## Conditions studied

- Cancer of the Esophagus

## Interventions

- **PROCEDURE:** Resective surgery

## Key facts

- **NCT ID:** NCT02415101
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2019-04-19
- **Final completion:** 2024-08-05
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02415101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02415101, "Timing of Resective Surgery After Neoadjuvant Chemoradiotherapy in Esophageal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02415101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*